tiprankstipranks
Embry Holdings Limited (HK:1388)
:1388
Hong Kong Market
Want to see HK:1388 full AI Analyst Report?

Embry Holdings Limited (1388) AI Stock Analysis

0 Followers

Top Page

HK:1388

Embry Holdings Limited

(1388)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
HK$0.26
▼(-34.75% Downside)
Action:Reiterated
Date:08/06/26
The score is primarily held back by weak financial performance—ongoing net and operating losses and recently negative operating/free cash flow—despite strong gross margins and manageable leverage. Technicals add further pressure with a clear downtrend and negative MACD, while valuation is constrained by a negative P/E and no stated dividend yield.
Positive Factors
High gross margins
Sustained gross margins around 70–75% indicate durable product-level economics and pricing power in intimate apparel. This margin buffer supports profitability potential if operating costs are controlled and underpins long-term ability to fund marketing, channel expansion, and product development.
Negative Factors
Persistent operating and net losses
Consistent operating and net losses indicate the company is not yet converting strong gross margins into sustainable profitability. Over time, continued losses erode retained earnings, limit reinvestment capacity and raise the need for structural cost reduction or business-model changes.
Read all positive and negative factors
Positive Factors
Negative Factors
High gross margins
Sustained gross margins around 70–75% indicate durable product-level economics and pricing power in intimate apparel. This margin buffer supports profitability potential if operating costs are controlled and underpins long-term ability to fund marketing, channel expansion, and product development.
Read all positive factors

Embry Holdings Limited (1388) vs. iShares MSCI Hong Kong ETF (EWH)

Embry Holdings Limited Business Overview & Revenue Model

Company Description
Embry Holdings Limited operates as an investment holding company primarily focused on the entire lifecycle of women's intimate apparel, encompassing design, research, development, manufacturing, and distribution. Its product offerings include bras...
How the Company Makes Money
Embry Holdings Limited makes money mainly by selling women’s lingerie and related intimate apparel products through branded channels. Its core revenue is generated from: (1) Retail sales via self-operated stores and counters, where the company ear...

Embry Holdings Limited Financial Statement Overview

Summary
Despite very strong gross margins (~70–75%) and manageable leverage (debt-to-equity ~0.31 in 2025), results are pressured by persistent operating and net losses (2025 net margin about -22%) and a clear deterioration in cash generation (2025 operating cash flow -26.6M; free cash flow -37.2M), alongside declining equity over time.
Income Statement
28
Negative
Balance Sheet
58
Neutral
Cash Flow
32
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.17B1.15B1.28B1.33B1.65B
Gross Profit818.45M848.67M956.10M1.00B1.21B
EBITDA-120.55M-268.27M15.40M65.16M131.00M
Net Income-253.18M-373.44M-72.17M-51.24M-27.48M
Balance Sheet
Total Assets2.32B2.37B2.86B2.98B3.30B
Cash, Cash Equivalents and Short-Term Investments189.79M163.43M283.61M380.18M378.64M
Total Debt476.52M363.43M342.33M384.05M425.35M
Total Liabilities775.23M642.66M704.09M704.47M788.50M
Stockholders Equity1.55B1.72B2.16B2.27B2.52B
Cash Flow
Free Cash Flow-37.17M-90.39M9.81M116.54M154.28M
Operating Cash Flow-26.61M-81.62M37.95M137.71M166.04M
Investing Cash Flow-17.95M-8.73M-17.00M-27.45M-11.54M
Financing Cash Flow41.05M-3.11M-101.46M-74.50M-215.72M

Embry Holdings Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.40
Price Trends
50DMA
0.27
Positive
100DMA
0.29
Negative
200DMA
0.34
Negative
Market Momentum
MACD
<0.01
Negative
RSI
63.38
Neutral
STOCH
79.08
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1388, the sentiment is Positive. The current price of 0.4 is above the 20-day moving average (MA) of 0.27, above the 50-day MA of 0.27, and above the 200-day MA of 0.34, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 63.38 is Neutral, neither overbought nor oversold. The STOCH value of 79.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1388.

Embry Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
HK$625.13M4.305.83%5.61%-1.84%29.22%
62
Neutral
HK$54.09B10.0312.10%5.90%1.86%-27.58%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
59
Neutral
HK$3.18B11.009.33%6.32%-1.56%53.99%
58
Neutral
HK$325.75M3.686.65%0.00%0.41%
51
Neutral
HK$244.04M-1.90-10.95%4.00%-16.20%-324.90%
43
Neutral
HK$114.05M-0.47-15.72%4.09%5.51%30.14%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1388
Embry Holdings Limited
0.28
-0.16
-37.50%
HK:2313
Shenzhou International Group Holdings
35.26
-22.03
-38.46%
HK:0311
Luen Thai Holdings Limited
0.31
0.08
35.96%
HK:3322
Win Hanverky Holdings Limited
0.20
0.00
0.00%
HK:2199
Regina Miracle International (Holdings) Limited
2.53
0.54
26.88%
HK:2298
Cosmo Lady (China) Holdings Co. Ltd.
0.29
-0.06
-17.15%

Embry Holdings Limited Corporate Events

Embry Holdings Names New Company Secretary and Authorised Representative
Jul 15, 2026
Embry Holdings Limited has announced changes to its corporate governance functions, with long-serving company secretary Ms. So Ka Man stepping down from her roles as company secretary and authorised representative effective 15 July 2026. The board...
Embry Holdings Wins Strong Shareholder Backing for All AGM Resolutions
May 28, 2026
Embry Holdings Limited reported that shareholders overwhelmingly approved all resolutions at its annual general meeting held on 28 May 2026, including the receipt of the 2025 audited financial statements and the re-election of directors Ms. Cheng ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 06, 2026